An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers-Reference-Cited by-同舟云学术

An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

Published:2016-04-27 Issue:2 Volume:157 Page:319-327
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Madorsky-Feldman Dana,Sklair-Levy Miri,Perri Tamar,Laitman Yael,Paluch-Shimon Shani,Schmutzler Rita,Rhiem Kerstin,Lester Jenny,Karlan Beth Y.,Singer Christian F.,Van Maerken Tom,Claes Kathleen,Brunet Joan,Izquierdo Angel,Teulé Alex,Lee Jong Won,Kim Sung-Won,Arun Banu,Jakubowska Anna,Lubinski Jan,Tucker Katherine,Poplawski Nicola K.,Varesco Liliana,Bonelli Luigina Ada,Buys Saundra S.,Mitchell Gillian,Tischkowitz Marc,Gerdes Anne-Marie,Seynaeve Caroline,Robson Mark,Kwong Ava,Tung Nadine,Tessa Nalven,Domchek Susan M.,Godwin Andrew K.,Rantala Johanna,Arver Brita,Friedman Eitan

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-016-3805-0.pdf

Reference32 articles.

1. Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R (2014) Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation. Ann Intern Med 160(4):255–266

2. Armstrong AC, Evans DG (2014) Management of women at high risk of breast cancer. BMJ 348:g2756. doi: 10.1136/bmj.g2756

3. Marchetti C, De Felice F, Palaia I, Perniola G, Musella A, Musio D et al (2014) Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers. BMC Women’s Health 14:150–157. doi: 10.1186/s12905-014-0150-5

4. Walker JL, Powell CB, Chen LM, Carter J, Bae Jump VL, Prker LP et al (2015) Society of gynecologic oncology recommendations for the prevention of ovarian cancer. Cancer 121:2108–2120. doi: 10.1002/cncr.29321

5. Kramer JL, Velazquez IA, Chen BE, Rosenberg PS, Struewing JP, Greene MH (2005) Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriers. J Clin Oncol 23(34):8629–8635

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of an Italian Population-Based Programme for Risk Assessment and Genetic Counselling and Testing for BRCA1/2-Related Hereditary Breast and Ovarian Cancer after 10 Years of Operation: An Observational Study Protocol;Methods and Protocols;2024-08-13

2. Breast cancer screening in BRCA1/2 pathogenic sequence variant carriers during pregnancy and lactation;Clinical Imaging;2024-07

3. CA125 serum levels in BRCA1/BRCA2 pathogenic sequence variant carriers as an ovarian cancer screening tool– a longitudinal study;2024-05-31

4. Clinical breast exam contribution to breast cancer diagnosis in BRCA mutation carriers vs. average to intermediate risk women;Breast Cancer Research and Treatment;2024-05-26

5. Perceptions of surveillance with magnetic resonance imaging among women with a hereditary risk of breast cancer—A phenomenographic study;Journal of Advanced Nursing;2024-02-21